Claims
- 1. A compound of the formula: whereinR1 represents an unbranched alkyleneimino group with 4 to 6 carbon atoms optionally mono- or di-(alkyl of 1 to 3 carbon atoms)-substituted; R2 represents a hydrogen or halogen atom or a methyl or methoxy group; R3 represents a hydrogen atom, an alkyl group with 1 to 7 carbon atoms, a phenyl group optionally substituted by a halogen atom or a methyl or methoxy group, an alkyl group with 1 or 2 carbon atoms substituted by a hydroxy, alkoxy, alkanoyloxy, tetrahydrofuranyl, tetrahydropyranyl, cyclocalkyl or phenyl group, in which the alkoxy part can contain from 1 to 3 carbon atoms, the alkanoyloxy part can contain 2 or 3 carbon atoms and the cycloalkyl part can contain 3 to 7 carbon atoms, an alkenyl group with 3 to 6 carbon atoms, an alkynyl group with 3 to 5 carbon atoms, a carboxy group or an alkoxycarbonyl group with a total of 2 to 5 carbon atoms; R4 represents a hydrogen atom, a methyl, ethyl or allyl group; and W represents a methyl, hydroxymethyl, formyl, carboxyl, alkoxycarbonyl, cyanomethyl, 2-cyanoethyl, 2-carboxyethenyl, alkoxycarbonylmethyl, 2-alkoxycarbonyl-ethyl or 2-alkoxycarbonylethenyl group, in which each alkoxy part can contain from 1 to 4 carbon atoms and can be substituted by a phenyl group; and when R3 is other then hydrogen and/or the radical R1 contains an optically active carbon atom, the enantiomeres and the diastereomeres thereof or their mixtures; when W is carboxyl, a non-toxic salt thereof formed with an inorganic or organic base; or a non-toxic acid addition salt thereof formed by an inorganic or organic acid with the amino function in the R1-position.
- 2. A compound of claim 1, whereinR1 represents a pyrrolidino, piperidino, 4-methyl-piperidino, 3-methyl-piperidino, 3,3-dimethyl-piperidino, 3,5-dimethyl-piperidino or hexamethyleneimino group; R2 represents a hydrogen, fluorine or chlorine atom; R3 represents hydrogen atom, an alkyl group with 1 to 6 carbon atoms, a phenyl, methyl-phenyl, chloro-phenyl, methoxy-phenyl, cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, tetrahydrofuran-2-yl-methyl, tetrahydropyran-2-yl-methyl, propargyl, hydroxymethyl, ethoxymethyl, acetoxymethyl, propionyloxymethyl, carboxy, methoxycarbonyl, ethoxycarbonyl or propoxycarbonyl group or an alkenyl group with 3 or 4 carbon atoms; R4 represents a methyl, ethyl or allyl group; and W represents a methyl, hydroxymethyl, formyl, carbonyl, benzyloxycarbonyl, carboxymethyl, methoxycarbonylmethyl, ethoxycarbonylmethyl, cyanomethyl, 2-carboxy-ethyl, 2-ethoxycarbonyl-ethyl, 2-cyano-ethyl, 2-carboxy-ethenyl, 2-ethoxycarbonyl-ethenyl or 2-cyano-ethenyl group or an alkoxycarbonyl group with 1 to 4 carbon atoms in the alkoxy part; and when R3 is other then hydrogen and/or R1 represents the 3-methyl-piperidino group, the enantiomeres and the diastereomeres thereof or their mixtures; when W is carboxyl, a non-toxic salt thereof formed with an inorganic or organic base; or a non-toxic acid addition salt thereof formed by an inorganic or organic acid with the amino function in the R1-position.
- 3. A compound of claim 1, whereinR1 represents a piperidino group; R2 represents a hydrogen atom; R3 represents an alkyl group with 1 to 6 carbon atoms, an alkenyl group with 3 or 4 carbon atoms, a phenyl, tetrahydropyran-2-yl-methyl, cyclopropylmethyl or cyclohexylmethyl group; R4 represents a methyl, ethyl or allyl group; and W represents a carboxyl, methoxycarbonyl, ethoxycarbonyl or cyanomethyl group; and the enantiomeres thereof or their mixtures; when W is carboxyl, a non-toxic salt thereof formed with an inorganic or organic base; or a non-toxic acid addition salt thereof formed by an inorganic or organic acid with the piperidino function.
- 4. A compound of claim 1, whereinR1 represents a piperidino group; R2 represents a hydrogen atom; R3 represents an alkyl group with 3 to 6 carbon atoms, an alkenyl group with 3 or 4 carbon atoms, a phenyl, cyclopropylmethyl or cyclohexylmethyl group; R4 represents a methyl or ethyl group; and W represents a carboxyl group; and the enantiomeres thereof or their mixtures; a non-toxic salt thereof formed with an inorganic or organic base; or a non-toxic acid addition salt thereof formed by an inorganic or organic acid with the piperidino function.
- 5. A compound of claim 1, whereinR1 represents a piperidino group; R2 represents a hydrogen atom; R3 represents an alkyl group with 3 to 6 carbon atoms, a 2-methyl-1-propen-1-yl, cyclomethylpropyl or cyclohexylmethyl group; R4 represents a methyl or ethyl group; and W represents a carboxyl group; and the enantiomeres thereof or their mixtures; a non-toxic salt thereof formed with an inorganic or organic base; or a non-toxic acid addition salt thereof formed by an inorganic or organic acid with the piperidino function.
- 6. A compound of claim 5, whereinR3 represents a n-propyl, n-butyl, isobutyl, sec.butyl, n-pentyl, 2-methyl-1-propen-1-yl, cyclomethylpropyl or cyclohexylmethyl group; the enantiomeres thereof or their mixtures; a non-toxic salt thereof formed with an inorganic or organic base; or a non-toxic acid addition salt thereof formed by an inorganic or organic acid with the piperidino function.
- 7. A compound of claim 5, whereinR3 represents a n-propyl, n-butyl, isobutyl, sec.butyl or n-pentyl group; and the enantiomeres thereof or their mixtures; a non-toxic salt thereof formed with an inorganic or organic base; or a non-toxic acid addition salt thereof salt thereof formed by an inorganic or organic acid with the piperidino function.
- 8. The compound of claim 5, which is 2-ethoxy-4-[N-(1-(2-piperidino-phenyl)-1-butyl)-aminocarbonylmethyl]-benzoic acid; the enantiomeres thereof or their mixtures; a non-toxic salt thereof formed with an inorganic or organic base; or a non-toxic acid addition salt formed by an inorganic or organic acid with the piperidino function.
- 9. The compound of claim 5, which is 2-ethoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]benzoic acid; the enantiomeres thereof or their mixtures; a non-toxic salt thereof formed with an inorganic or organic base; or a non-toxic acid addition salt formed by an inorganic or organic acid with the piperidino function.
- 10. The compound of claim 5, which is form (A) of 2-ethoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoic acid, recrystallized from acetone/petroleum ether, having a melting point of 90°-92° C.
- 11. The compound of claim 5, which is form (B) of 2-ethoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoic acid, recrystallized from ethanol/water, having a melting point of 140°-142° C.
- 12. The compound of claim 5, which is form (C) of 2-ethoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoic acid, recrystallized from methanol, having a melting point of 74°-85° C.
- 13. The compound of claim 5, which is 2-ethoxy-4-[N-(α-cyclohexylmethyl-2-piperidino-benzyl)-aminocarbonylmethyl]-benzoic acid; the enantiomeres thereof or their mixtures; a non-toxic salt thereof formed with an inorganic or organic base; or a non-toxic acid addition salt formed by an inorganic or organic acid with the piperidino function.
- 14. The (S)-enantiomer of a compound as claimed in anyone of the claims 1 to 13; when W is carboxy, a non-toxic salt thereof formed with an inorganic or organic base; or a non-toxic acid addition salt formed by an inorganic or organic acid with the amino function in the R1-position.
- 15. A hypoglycemic pharmaceutical composition consisting essentially of an inert pharmaceutical carrier and an effective hypoglycemic amount of a compound of claim 1.
Priority Claims (3)
Number |
Date |
Country |
Kind |
3347565 |
Dec 1983 |
DE |
|
3522604 |
Jun 1985 |
DE |
|
3523466 |
Jul 1985 |
DE |
|
Parent Case Info
This application is a reissue of Ser. No. 07/495,820 filed Mar. 19, 1990 now U.S. Pat. No. 5,216,167 which is a continuation of application Ser. No. 302,022, filed Jan. 25, 1989 (abandoned), which is a continuation-in-part of co-pending application Ser. No. 872,706 filed Jun. 10, 1986, (abandoned) which is a continuation-in-part of application Ser. No. 684,054 filed Dec. 20, 1984, now abandoned; and a continuation-in-part of co-pending application Ser. No. 878,921 filed Jun. 26, 1986 (abandoned).
US Referenced Citations (10)
Foreign Referenced Citations (5)
Number |
Date |
Country |
0147830 |
Oct 1985 |
EP |
2090834A |
Jul 1982 |
GB |
2091729A |
Aug 1982 |
GB |
2100261 |
Dec 1982 |
GB |
2124220 |
Feb 1984 |
GB |
Non-Patent Literature Citations (2)
Entry |
Frahm & Knapp, Tetrahedron Letters, vol. 22, 28, pp. 2633-2636 (1981). |
Demailly and Solladie, Tetrahedron Letters, vol. 29, pp 1472 (1975). |
Divisions (1)
|
Number |
Date |
Country |
Parent |
07/495820 |
Mar 1990 |
US |
Child |
08/946602 |
|
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
07/302022 |
Jan 1989 |
US |
Child |
07/495820 |
|
US |
Continuation in Parts (3)
|
Number |
Date |
Country |
Parent |
06/872706 |
Jun 1986 |
US |
Child |
07/302022 |
|
US |
Parent |
06/684054 |
Dec 1984 |
US |
Child |
06/872706 |
|
US |
Parent |
06/878921 |
Jun 1986 |
US |
Child |
06/684054 |
|
US |
Reissues (1)
|
Number |
Date |
Country |
Parent |
07/495820 |
Mar 1990 |
US |
Child |
08/946602 |
|
US |